van der Vaart Sandra D 4
4 · LABCORP HOLDINGS INC. · Filed Aug 15, 2025
Insider Transaction Report
Form 4
van der Vaart Sandra D
EVP, Corporate Affairs
Transactions
- Sale
Common Stock
2025-08-13$271.42/sh−3,903$1,059,371→ 2,273.669 total - Exercise/Conversion
Common Stock
2025-08-13$131.43/sh+3,903$512,971→ 6,176.669 total - Exercise/Conversion
Non-qualified Stock Options
2025-08-13−3,903→ 0 totalExercise: $131.43From: 2020-02-12Exp: 2029-02-11→ Common Stock (3,903 underlying)
Footnotes (4)
- [F1]Amount includes 30.1294 shares acquired on June 30, 2025 under the Labcorp Holdings Inc. Amended and Restated 2016 Employee Stock Purchase Plan.
- [F2]Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan.
- [F3]Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Labcorp Holdings Inc. ("Labcorp"), calculated pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea.
- [F4]The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable.